Rémi Bonjean: The 1st VHHs Against Active Rap1 to Monitor Platelet Activation
Rémi Bonjean, R and D Project Manager at Nanomunity, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I share with you the work we have done in collaboration with the Pr Marie-Christine Alessi from Cardiovascular and Nutrition Research Center – (C2VN) and Dr Patrick Chames in the article ‘Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers’ a method article published in the journal Research and Practice in Thrombosis and Haemostasis.
In this article, we successfully developed, produced the first generation of VHHs against active Rap1 as promising tools to quantify active Rap1 levels in platelets and facilitate clinical studies to monitor platelet Rap1 activation in various medical contexts.
I would like to thank all authors who contributed to this collaboration especially Pr Marie-Christine Alessi, Dr Patrick Chames, Dr Maxime Moulard and Marielle Margier.”
Title: Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers
Authors: Marie-Christine Alessi, Maxime Moulard, Daniele Boulay-Moine, Cyril Pons, Marielle Margier, Cléa Vessière, Marjorie Poggi, Theo Pigaglio, Francoise Dignat-George, Alain Roussel, Stéphane Burtey, Laurent Bonello, Patrick Chames, Remi Bonjean, Franck Peiretti
Read the Full Article on RPTH Journal
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications